Wen-Lin Kuo

National Chung Cheng University — Taiwan

Biochemistry, Genetics and Molecular Biology · Life Sciences

21h-index4.9kcitations84works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genomic variations and chromosomal abnormalities(20), RNA modifications and cancer(10), Melanoma and MAPK Pathways(10), Breast Cancer Treatment Studies(8), Cancer-related Molecular Pathways(7)

Publications84 total

Association of Fusobacterium nucleatum with suppressed anti-tumor T cell responses in gastric cancer
2026Open Access
Efficacy comparison of anthracycline and taxane when added to immune checkpoint inhibitor in neoadjuvant chemotherapy of triple negative breast cancer: Clinical evidence from size-reduction measurement by ultrasound.
Journal of Clinical Oncology·2023
Data from Yin Yang 1 Modulates Taxane Response in Epithelial Ovarian Cancer
2023Open Access
Supplementary Data from Yin Yang 1 Modulates Taxane Response in Epithelial Ovarian Cancer
2023Open Access
Supplementary Data from Yin Yang 1 Modulates Taxane Response in Epithelial Ovarian Cancer
2023Open Access
Data from Yin Yang 1 Modulates Taxane Response in Epithelial Ovarian Cancer
2023Open Access
Supplementary Figures S1-S2 from Amplification of <i>PVT1</i> Contributes to the Pathophysiology of Ovarian and Breast Cancer
2023Open Access
Data from Amplification of <i>PVT1</i> Contributes to the Pathophysiology of Ovarian and Breast Cancer
2023Open Access
Supplementary Tables S1-S4 from Amplification of <i>PVT1</i> Contributes to the Pathophysiology of Ovarian and Breast Cancer
2023Open Access
Supplementary Tables S1-S4 from Amplification of <i>PVT1</i> Contributes to the Pathophysiology of Ovarian and Breast Cancer
2023Open Access
Supplementary Figures S1-S2 from Amplification of <i>PVT1</i> Contributes to the Pathophysiology of Ovarian and Breast Cancer
2023Open Access
Data from Amplification of <i>PVT1</i> Contributes to the Pathophysiology of Ovarian and Breast Cancer
2023Open Access
Data from Array-Based Comparative Genomic Hybridization Analysis Identified Cyclin D1 as a Target Oncogene at 11q13.3 in Nasopharyngeal Carcinoma
2023Open Access
Supplementary Tables 1-3 from An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer
2023Open Access
Data from Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition
2023Open Access
Supplementary Figure 1 from Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition
2023Open Access
Supplementary Table Legends 1-3 from An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer
2023Open Access
Supplementary Table Legends 1-3 from An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer
2023Open Access
Supplementary Figure 2 from Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition
2023Open Access
Supplementary Figure Legends 1-2 from Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Joe W. Gray(24), Gordon B. Mills(13), Y. Guan(11), Chi‐Chang Yu(8), Shin‐Cheh Chen(8), Richard M. Neve(8), Zhiwei Hu(8), Shih‐Che Shen(7), Shir‐Hwa Ueng(6), Yung‐Feng Lo(5), Hsiu-Pei Tsai(5), Olga K. Mirzoeva(5), Debopriya Das(5), Laura M. Heiser(5), Doris R. Siwak(5), Rina Gendelman(5), Nora Bayani(5), Nicholas J. Wang(5), Zachary A. Knight(5), Heidi S. Feiler(5)